Innovation In Science and Medicine: Potential Implications for Health Policy? - The Chancellor’s Health Policy Lecture Series

Summary: Dr. Hal Barron discusses what he has learned about innovation in science and medicine based on his over 20 years of experience in the biotechnology industry, and potential implications for health policy at the local, national and global level. Barron is one of the most respected clinician-scientists and successful drug developers in the biotechnology industry and serves as Calico’s president of research and development. Series: "Philip R. Lee Institute for Health Policy Studies" [Professional Medical Education] [Show ID: 32821]